We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+1.33%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$23.8B
AUM Growth
Cap. Flow
+$24B
Cap. Flow %
100.94%
Top 10 Hldgs %
6.06%
Holding
3,034
New
3,025
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Financials 11.51%
2 Technology 10.18%
3 Industrials 9.39%
4 Healthcare 9.01%
5 Consumer Discretionary 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GERN icon
2976
Geron
GERN
$828M
$23K ﹤0.01%
+16,172
New +$17.6K
IJJ icon
2977
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.83B
$23K ﹤0.01%
+460
New +$23.3K
GV
2978
DELISTED
Goldfield Corporation
GV
$23K ﹤0.01%
+10,655
New +$28.5K
CYTR
2979
DELISTED
CytRx Corp
CYTR
$23K ﹤0.01%
+1,951
New +$28.8K
ANTH
2980
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$21K ﹤0.01%
+712
New +$26.6K
UPI
2981
DELISTED
UROPLASTY INC-NEW
UPI
$21K ﹤0.01%
+10,051
New +$23K
CVM icon
2982
CEL-SCI Corp
CVM
$20.3M
$20K ﹤0.01%
+12
New +$23.1K
SDEV
2983
Stablecoin Development Corp
SDEV
$58M
0
SSKN
2984
DELISTED
Strata Skin Sciences
SSKN
$20K ﹤0.01%
+42
New +$22.5K
TELL
2985
DELISTED
Tellurian Inc.
TELL
$20K ﹤0.01%
+2,440
New +$20.7K
MJES
2986
DELISTED
MAJESCO HOLDINGS INC. NEW
MJES
$20K ﹤0.01%
+34,253
New +$20K
PZG icon
2987
Paramount Gold Nevada
PZG
$96.1M
$19K ﹤0.01%
+16,346
New +$24.7K
GMO
2988
DELISTED
General Moly, Inc.
GMO
$19K ﹤0.01%
+10,396
New +$20.5K
DVAX
2989
DELISTED
Dynavax Technologies
DVAX
$18K ﹤0.01%
+1,630
New +$34.3K
AUMN
2990
DELISTED
Golden Minerals Company
AUMN
$18K ﹤0.01%
+521
New +$22.4K
GSI
2991
DELISTED
GENERAL STL HLDGS INC COM NEW (NV)
GSI
$18K ﹤0.01%
+3,549
New +$17.8K
MEA
2992
DELISTED
METALICO INC
MEA
$18K ﹤0.01%
+14,885
New +$22.2K
IRD
2993
Opus Genetics
IRD
$306M
$17K ﹤0.01%
+82
New +$14.1K
LOCM
2994
DELISTED
LOCAL CORP COM STK (DE)
LOCM
$17K ﹤0.01%
+10,122
New +$17.1K
SVRA icon
2995
Savara
SVRA
$1.12B
$15K ﹤0.01%
+509
New +$22.6K
YTEN
2996
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
0
CRDC
2997
DELISTED
CARDICA INC COM NEW (DE)
CRDC
$15K ﹤0.01%
+1,351
New +$17K
VRS
2998
DELISTED
VERSO CORP COM STK (DE)
VRS
$15K ﹤0.01%
+13,321
New +$15.5K
ETRM
2999
DELISTED
EnteroMedics Inc.
ETRM
$15K ﹤0.01%
+12
New +$12.7K
COB
3000
DELISTED
COLUMBIA LABORATORIE INC
COB
$15K ﹤0.01%
+23,380
New +$15K

Similar funds

Guggenheim Capital's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Guggenheim Capital, which disclosed 3,034 positions worth $23.8B. Its ten largest holdings account for 6.1% of the portfolio.

Its largest position is State Street SPDR S&P 500 ETF Trust: 2,235,283 shares worth $359M.

By sector, the portfolio is most concentrated in Financials at 12% of assets, followed by Technology and Industrials.

  • Guggenheim Capital's largest Q2 2013 buy was State Street SPDR S&P 500 ETF Trust: 2,235,283 shares worth $359M.
  • Guggenheim Capital's ten largest holdings make up 6.1% of its $23.8B portfolio in Q2 2013.
  • Guggenheim Capital disclosed 3,034 positions in Q2 2013, its first 13F filing on record.

Based on Guggenheim Capital's 13F filing for Q2 2013, filed 14 Aug 2013.